We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Software for Rapid Cell Count and Analysis

By Biotechdaily staff writers
Posted on 05 Apr 2004
New software is based on an innovative cluster analysis algorithm designed to provide more precise, accurate, and automated absolute cell counting and viability measurements.

Accuracy, reproducibility, and standardization are essential to successful outcomes in laboratories that perform cell count and viability assessments. More...
Traditional methods for counting cells and assessing cell viability are time consuming. Moreover, they may produce variable results because of reliance on subjective visual discrimination of dye-stained cells using a hemacytometer and microscope.

The ViaCount Assay of Guava Technologies, Inc. (Hayward, CA, USA) is a simple, accurate, and reproducible test for absolute cell counting and viability measurements that overcomes many of the limitations of traditional methods. The assay reduces statistical variation by sampling large numbers of single cells, and miniaturizes operator variability by using fluorescence intensity measurements to categorize cells as live, dead, or apoptotic. Now, the system is enhanced with the Guava EasyFit software feature that automates and standardizes cell counting and viability assessments.

The software provides a computer-assisted clustering algorithm to group cellular distributions based on their positions in a 3D matrix. Cells are classified and counted based on three individual measurements of each cell, including the fluorescence intensity values for the live and dead cell based on the uptake of dyes in Guava's ViaCount solution.

"EasyFit provides users of our product with a means to operate the system without the need for manual adjustment of gating parameters,” said Keith Olson, director of product commercialization at Guava Technologies. The company is a leading provider of integrated microcytometry and cell counting systems for the life science, biotechnology, and pharmaceutical industries, as well as for use in clinical testing and blood processing and other areas where single cell counting is important.




Related Links:
Guava Technologies

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LIAISON Murex Anti-HDV Immunoassay is the first fully automated FDA-authorized immunoassay for HDV detection in the U.S. (Photo courtesy of Diasorin)

Fully Automated Immunoassay Test Detects HDV Co‑Infection and Super-Infection

Hepatitis delta, also known as hepatitis D, is caused by the hepatitis delta virus (HDV). It is a viral liver infection that can result in one of the most severe forms of viral hepatitis.... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.